New discovery in malaria

October 02, 2002

Scientists at NYU School of Medicine have for the first time identified genes in mosquitoes that reduce the natural transmission of the most lethal malaria parasite.

In the October 4 issue of Science, the researchers report that they have discovered genes in naturally occurring populations of the mosquito, Anopheles gambiae, that enable the insects to resist infection by the malaria parasite, Plasmodium falciparum, which is deadly when transmitted to humans though an insect bite. The finding potentially opens new avenues to preventing malaria, one of the world's greatest scourges.

"The new genes we have found are the first ones that make the Anopheles mosquito highly resistant to real, natural populations of the most deadly of the human malaria parasites, as opposed to laboratory parasite strains, and there are several ways that this basic research finding could help prevent malaria transmission," says Kenneth Vernick, Ph.D., Associate Professor in the Department of Medical and Molecular Parasitology, who led the research.

Although it is too soon to know whether the research will result in new treatments or prevention strategies, Dr. Vernick says it may be possible to spread the parasite-blocking genes among mosquito populations, and thereby deny the parasite enough mosquitoes to sustain itself in nature. The genes might also produce a parasite-killing compound that could be developed into a drug for human use, he speculates.

Malaria is transmitted from person to person through the bite of female mosquitoes in the genus Anopheles, which carry malaria parasites. In order to sustain itself, the parasite must undergo a part of its lifecycle inside of the mosquito.

Dr. Vernick says that the genes that were found appear to have a large effect on the parasite's growth. In one case, mosquitoes with two copies of a parasite-blocking gene had an average of 0.2 parasites per mosquito, while insects with two copies of the alternate form of the gene, which makes insects susceptible to the parasite, had an average of 50 parasites per mosquito.

It isn't yet known how many parasite-blocking genes there are in the Anopheles mosquito, or how common these genes are in nature. Dr. Vernick estimates that at least half of the mosquitoes in natural populations may carry genes for resistance. Then why do they still transmit malaria? "It's likely that for many or most of the genes for resistance, the parasite develops its own 'counter-resistance' genes. There has been the general idea that the African malaria parasite and its mosquito vector were co-adapted, that is, they had arrived at a stable evolutionary relationship. Clearly, from our work, nothing could be farther from the truth.

"There is a high frequency of resistance genes in mosquitoes in nature, indicating that the parasite and the mosquito are in an intense evolutionary battle. The vector is trying to escape the parasite by developing a myriad of resistance mechanisms. The parasite, of course, doesn't want to go extinct, so it is permanently compelled to develop counter-measures to these mechanisms," says Dr. Vernick.

In addition to the genes that were found, the new study is novel because naturally occurring mosquitoes in a part of Africa where malaria is endemic were genetically screened by linkage analysis in the outbred population.

The study took place in Mali in West Africa. Dr. Vernick and NYU colleagues Oumou Niaré and Frederick Odoul collected some 5,000 mosquitoes that had bitten people infected with malaria, and counted the number of oocysts, one of the life stages of the malaria parasite, in the guts of the insects. They also extracted DNA from the insects in order to perform genetic screens. The mosquitoes that were analyzed were the offspring of wild mosquitoes from a village in Mali where malaria is endemic. Because female mosquitoes mate only once, the offspring analyzed in the study came from a single-pair mating that happened in nature. This approach insured that the results gave an accurate picture of the real mosquito genes that block the actual parasites currently infecting people in the endemic area.
The software used for the genetic analysis was designed by Kyriacos Markianos and Leonid Kruglyak from the Fred Hutchinson Cancer Research Center in Seattle, who are co-authors on the study. The software was designed to map the location on the mosquito's chromosomes of genes that influenced the number of parasitic oocysts.

Dr. Vernick's co-authors on the study are Oumou Niaré and Frederick Oduol from NYU School of Medicine; Kyriacos Markianos and Leonid Kruglyak from Fred Hutchinson Cancer Research Center; Jennifer Volz, Fotis Kafatos, Claudia Blass, and Rui Wang from the European Molecular Biology Laboratories in Heidelberg, Germany; and Abdoulaye Touré, Magaran Bagayoko, Djibril Sangaré, Sekou Traoré, Guimogo Dolo, Madama Bouaré, and Yeya Toure from the University of Mali School of Medicine in Bamako.

The study was supported by grants from NIAID/National Institutes of Health.

NYU Langone Medical Center / New York University School of Medicine

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to